What does Longeveron Inc. do?

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors…

What is Longeveron Inc.'s P/E and P/B ratio?

Longeveron Inc. has a P/E ratio of -0.2 and a P/B ratio of 0.49.

What is Longeveron Inc.'s debt-to-equity ratio?

Longeveron Inc. has a debt-to-equity ratio of 0.06.

How much does Longeveron Inc. owe compared with what it owns?

Longeveron Inc. owes $0.33 for every $1 it owns (balance sheet Jun 2026), which is low.

Does Longeveron Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Longeveron Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 25 Mar 2026). It has no yellow flags.

Where can I read the latest news about Longeveron Inc.?

Recent headlines about Longeveron Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Longeveron Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Longeveron Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Longeveron Inc.

Q: What is Longeveron Inc.'s Positivity rank?

Longeveron Inc. is ranked #2,141 of 6,774 companies globally and #602 of 4,000 in United States on PositoAI, with a Positivity Score of 21,846.

NasdaqCM: LGVN · Healthcare

Positivity Index

#2,141 / 6,774

Global

#602 / 4,000

United States

Positivity Score

21,846

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 25 Mar 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Longeveron Inc. — Overview & Financial Snapshot

Longeveron Inc. (NasdaqCM: LGVN) is a Healthcare company, ranked #2,141 of 6,774 companies globally and #602 of 4,000 in United States on PositoAI, with a Positivity Score of 21,846. Its market capitalisation is ₹47.85 Cr ($5.07M), P/E ratio is -0.2 and P/B ratio is 0.49. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →